DISEASE SCANNER
Global Incurable Diseases Tracker
Dengue Fever
Mosquito-borne viral infection caused by dengue virus (4 serotypes). Transmitted by Aedes aegypti and Aedes albopictus. 100-400 million infections annually. Can progress to severe dengue (dengue hemorrhagic fever/shock syndrome).
390.0M
143
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1NS1 antigen test (early)
- 2IgM/IgG serology
- 3RT-PCR
- 4Complete blood count (thrombocytopenia)
- 5Hematocrit (hemoconcentration)
Prognosis
Usually self-limiting (2-7 days). Severe dengue: 1-5% mortality with treatment, <1% in experienced centers. 20-30% mortality without proper care.
Prevention
- Mosquito control (Aedes)
- Insect repellents
- Protective clothing
- Dengvaxia vaccine (seropositive only)
- Qdenga vaccine (new)
- Eliminating breeding sites
- Community education
Research Status
Dengvaxia vaccine (limited use: only seropositive individuals due to ADE risk). Qdenga (TAK-003) new vaccine approved. No specific antiviral. Supportive care critical. Warning signs recognition reduces mortality to <1%.
Affected Countries
Sources
- https://www.cdc.gov
- https://www.who.int
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.